Stay updated on CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.

Latest updates to the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe date has been updated from April 2, 2025, to June 11, 2025.SummaryDifference0.6%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check61 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check68 days agoChange DetectedThe page has been updated to reflect a new version release (v2.14.4) and the status of results has changed from 'Submitted' to 'Posted'.SummaryDifference2%
Stay in the know with updates to CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.